Signal
After promising to sell off 7% of its business back in november, charles river laboratories has delivered. the CRO is offloading its entire contract manufacturi
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-02-25 19:07 UTCUpdated 2026-02-25 19:07 UTC
rss
fierce_pharma
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (2 domains)domains are deduped. counts indicate coverage, not truth.2 top sources shown
limited source diversity in top sources
Overview
After promising to sell off 7% of its business back in November, Charles River Laboratories has delivered. The CRO is offloading its entire contract manufacturing operation and some of its European discovery service assets, which brought in a combined $287 million in revenue last year.
Score total
0.7
Momentum 24h
2
Posts
2
Origins
2
Source types
1
Duplicate ratio
50%
All evidence
All evidence
After promising to sell off 7% of its business back in November, Charles River Laboratories has delivered. The CRO is offloading its entire contract manufacturing operation and ...
Fierce Biotech · fiercebiotech.com · 2026-02-25 19:07 UTC
After promising to sell off 7% of its business back in November, Charles River Laboratories has delivered. The CRO is offloading its entire contract manufacturing operation and ...
Fierce Pharma (All) · fiercepharma.com · 2026-02-25 19:07 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 2Origin domains: 2Duplicates: -
Showing 2 / 0
Top publishers (this list)
- Fierce Biotech (1)
- Fierce Pharma (All) (1)
Top origin domains (this list)
- fiercebiotech.com (1)
- fiercepharma.com (1)